Severe hypophosphataemia following oral bisphosphonate treatment in a patient with osteoporosis

A 76-year-old woman was treated with oral bisphosphonate, alendronate, for osteoporosis in an outpatient clinic. Routine blood tests 4 months after alendronate prescription surprisingly revealed severe hypophosphataemia. The patient was hospitalised and treated with intravenous and oral phosphate su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Case Rep
Main Authors: Bagger, Louise Wulff, Hansen, Per Kim Dyhr, Schwarz, Peter, Nielsen, Barbara Rubek
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545506/
https://ncbi.nlm.nih.gov/pubmed/33033001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados